Sutro Biopharma, Inc. (STRO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 03:46PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 287.68M |
| Enterprise Value | -54.30M |
| Trailing P/E | 85.38 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.46 |
| Price/Book (mrq) | 1.92 |
| Enterprise Value/Revenue | -0.35 |
| Enterprise Value/EBITDA | 0.94 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.98 |
| 52-Week Change 3 | -29.30% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 6.1300 |
| 52 Week Low 3 | 2.0100 |
| 50-Day Moving Average 3 | 4.2922 |
| 200-Day Moving Average 3 | 3.9581 |
Share Statistics
| Avg Vol (3 month) 3 | 990.3k |
| Avg Vol (10 day) 3 | 631.31k |
| Shares Outstanding 5 | 76.92M |
| Implied Shares Outstanding 6 | 81.76M |
| Float 8 | 49.42M |
| % Held by Insiders 1 | 0.90% |
| % Held by Institutions 1 | 78.91% |
| Shares Short (Apr 15, 2024) 4 | 2.18M |
| Short Ratio (Apr 15, 2024) 4 | 1.48 |
| Short % of Float (Apr 15, 2024) 4 | 2.86% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.84% |
| Shares Short (prior month Mar 15, 2024) 4 | 2.32M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -69.47% |
| Operating Margin (ttm) | 37.94% |
Management Effectiveness
| Return on Assets (ttm) | -12.71% |
| Return on Equity (ttm) | -58.25% |
Income Statement
| Revenue (ttm) | 153.73M |
| Revenue Per Share (ttm) | 2.56 |
| Quarterly Revenue Growth (yoy) | 1,217.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -82.46M |
| Net Income Avi to Common (ttm) | -106.79M |
| Diluted EPS (ttm) | -1.7800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 375.62M |
| Total Cash Per Share (mrq) | 6.01 |
| Total Debt (mrq) | 33.63M |
| Total Debt/Equity (mrq) | 22.48% |
| Current Ratio (mrq) | 4.50 |
| Book Value Per Share (mrq) | 2.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111.62M |
| Levered Free Cash Flow (ttm) | -30.58M |
© 2024 Yahoo. All rights reserved.